naltrexone drug
Evidence from:
primary |
all sources
Related entities (6)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| naltrexone | protective_against | alcoholism | — | 2 |
| naltrexone | protective_against | Alcohol Use Disorder | — | 2 |
| naltrexone | associated_with | auditory | — | 1 |
| naltrexone | protective_against | binge eating | — | 1 |
| naltrexone | targets | OPRM1 | — | 6 |
| OPRM1 A118G | interacts_with | naltrexone | — | 4 |
Mentioned in (7)
Papers in which this entity is mentioned.
- Association Between Benzodiazepine or Z-Drug Prescriptions and Drug-Related Poisonings Among Patients Receiving Buprenorphine Maintenance: A Case-Crossover Analysis. (2021)
- Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. (2021)
- Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol. (2020)
- Hypermethylation of Proopiomelanocortin and Period 2 Genes in Blood Are Associated with Greater Subjective and Behavioral Motivation for Alcohol in Humans. (2019)
- Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans. (2015)
- Effects of alcohol on the endocrine system. (2013)
- Assessment of benefits of a universal screen for maternal alcohol use during pregnancy. (2010)
Merged raw entities (7)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| naltrexone | drug | 29 | 109 |
| long-acting naltrexone | drug | 1 | 1 |
| opioid receptor antagonist | drug | 1 | 2 |
| oral naltrexone | drug | 1 | 1 |
| mor antagonist naltrexone | drug | — | — |
| opiate antagonist | drug | — | — |
| opioid antagonist naltrexone | drug | — | — |